Therefore, to create an accurate starting ratio of tumor to T cells in the tumor microenvironments, we transferred one million therapeutic CD8+ T cells into each mouse bearing an established B16-F10 tumor that had been grown for 10 days. Here, CD8A is linked to neoplasm.